Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lala

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 1, 2016
Synaptic Contributions to Receptive Field Structure and Response Properties in the Rodent Lateral Geniculate Nucleus of the ThalamusVandana Suresh, Ulaş M Çiftçioğlu, Xin Wang, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 10, 2006
Elevated procalcitonin as a diagnostic marker in meningococcal diseaseG D Mills, H M Lala, M R Oehley, et al.
Thrombosis and Haemostasis|June 4, 2009
Ankle exercise and venous blood velocityPaul D Stein, Abdo Y Yaekoub, Syed T Ahsan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2021
First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer<sup>☆</sup>J Niu, C Maurice-Dror, D H Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2026
Corrigendum to "Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial": [Ann Oncol 36 (2025) 775-785]E Felip, C I Rojas, M Schenker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2025
Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trialE Felip, C I Rojas, M Schenker, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 1, 2016
Synaptic Contributions to Receptive Field Structure and Response Properties in the Rodent Lateral Geniculate Nucleus of the ThalamusVandana Suresh, Ulaş M Çiftçioğlu, Xin Wang, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 10, 2006
Elevated procalcitonin as a diagnostic marker in meningococcal diseaseG D Mills, H M Lala, M R Oehley, et al.
Thrombosis and Haemostasis|June 4, 2009
Ankle exercise and venous blood velocityPaul D Stein, Abdo Y Yaekoub, Syed T Ahsan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2021
First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer<sup>☆</sup>J Niu, C Maurice-Dror, D H Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2026
Corrigendum to "Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial": [Ann Oncol 36 (2025) 775-785]E Felip, C I Rojas, M Schenker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2025
Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trialE Felip, C I Rojas, M Schenker, et al.
Pageof 4